Indication
Chinese
1 clinical trial
2 products
Product
EtripamilClinical trial
A Single Center, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Etripamil in Healthy Chinese SubjectsStatus: Completed, Estimated PCD: 2023-03-26
Product
Placebo